Publications by authors named "Mari Anno"

Claim this Profile
P
Postprandial fatty acid-binding protein 4 is associated with muscle insulin resistance.
Tsuyoshi Okura, Yuichi Ito, Mari Anno, Satomi Endo, Sonoko Kitao

Diabetologia· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fasting hepatic insulin clearance reflects postprandial hepatic insulin clearance: a brief report.
Tsuyoshi Okura, Risa Nakamura, Sonoko Kitao, Yuichi Ito, Mari Anno

Diabetol Metab Syndr· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aldehyde dehydrogenase 2 polymorphism is an important gene for insulin resistance in Japanese patients with type 2 diabetes.
Tsuyoshi Okura, Risa Nakamura, Mari Anno, Yuichi Ito, Sonoko Kitao

Metabol Open· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retroperitoneal paraganglioma with loss of heterozygosity of the von Hippel-Lindau gene: a case report and review of the literature.
Mari Anno, Shoichiro Izawa, Yohei Fujioka, Kazuhiko Matsuzawa, Kohei Saito

Endocr J· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of pancreatic duodenal homeobox-1 () genetic polymorphism in insulin secretion in Japanese patients with type 2 diabetes.
Tsuyoshi Okura, Risa Nakamura, Yuichi Ito, Sonoko Kitao, Mari Anno

BMJ Open Diabetes Res Care· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dipeptidyl peptidase 4 inhibitor improves insulin resistance in Japanese patients with type 2 diabetes: a single-arm study, a brief report.
Tsuyoshi Okura, Yohei Fujioka, Risa Nakamura, Yuichi Ito, Sonoko Kitao, Mari Anno

Diabetol Metab Syndr· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The sodium-glucose cotransporter 2 inhibitor ipragliflozin improves liver function and insulin resistance in Japanese patients with type 2 diabetes.
Tsuyoshi Okura, Yohei Fujioka, Risa Nakamura, Sonoko Kitao, Yuichi Ito, Mari Anno

Sci Rep· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic insulin clearance is increased in patients with high HbA1c type 2 diabetes: a preliminary report.
Tsuyoshi Okura, Yohei Fujioka, Risa Nakamura, Mari Anno, Yuichi Ito

BMJ Open Diabetes Res Care· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis